- Research works
- 2 ▲ 82% vs 2013–17
- Citations
- 23 14.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 79% world 28%
Not ranked overall: PathoVacs (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does PathoVacs (United States) publish most on?
By volume in 2022–2025: Cellular transport and secretion, Parkinson's Disease Mechanisms and Treatments and Nerve injury and regeneration.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cellular transport and secretion Cell Biology 0 works
- 2 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 3 Nerve injury and regeneration Cellular and Molecular Neuroscience 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has PathoVacs (United States)'s research output changed?
Output in 2018–2022 was 82% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ames
- Iowa State University
- Ames National Laboratory
- National Animal Disease Center
- National Laboratory for Agriculture and the Environment
- NewLink Genetics (United States)
- Metabolic Technologies (United States)
- Sustainable Horizons Institute
- Mary Greeley Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.